Beta-blockers and psychometric performance: studies in normal volunteers.

Area of Science:

• Pharmacology
• Neuroscience
• Psychology

Background:

• Beta-adrenoceptor antagonists are widely prescribed medications.
• Their potential central nervous system (CNS) effects warrant investigation.
• Psychometric testing offers a method to assess cognitive and psychomotor performance.

Purpose of the Study:

• To evaluate the psychometric effects of beta-adrenoceptor antagonists in healthy volunteers.
• To compare the effects of a cardioselective (atenolol) and a non-selective (propranolol) beta-blocker.
• To assess the impact of both single and chronic dosing regimens.

Main Methods:

• Psychometric function tests were administered to young, healthy volunteers.
• Participants received single doses of atenolol and propranolol at varying dosages.
• A comparative study assessed propranolol, atenolol, and diazepam.
• Chronic administration of atenolol, nadolol, and diazepam was also evaluated over seven days.

Main Results:

• Single doses of atenolol showed dose-dependent psychomotor impairment, peaking at 200 mg.
• Propranolol caused significant psychomotor impairment inversely related to dose (maximal at 40 mg, minimal at 320 mg).
• Both drugs exhibited effects comparable in magnitude to diazepam.
• Chronic administration of atenolol, nadolol, and diazepam resulted in sporadic, not persistent, effects.

Conclusions:

• Beta-blockers demonstrate observable central effects in humans measurable by psychomotor tests.
• The clinical relevance of these central effects for maintenance therapy and skilled performance remains uncertain.
• Further research is needed to clarify the implications of beta-blocker-induced central effects.